Open an account

Bruker

BRKR · NASDAQ

$55.93+$0.56 (+1.01%)TodayMarket closed ·
Prev close $55.37

About BRKR

Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 11,085 full-time employees. The company went IPO on 2000-08-04. The firm's segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). Its BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research and development solutions in chemical research fields. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and others.

Employees
11,085
Headquarters
Billerica, Massachusetts
Listed
Aug 4, 2000
Sector
Health Care
Industry
Life Sciences Tools & Services
Website
bruker.com

BRKR key statistics

Market cap
8.52B
Price-earnings ratio
0.00
Dividend yield
0.64%
Average volume
2.16M
Volume
1.57M
Open price
$55.52
High today
$56.94
Low today
$54.85
52 Week high
$66.98
52 Week low
$32.37

Bruker (BRKR) at a glance

Bruker (BRKR) last traded at $55.93, with a market cap of 8.52B, a price-to-earnings ratio of 0.00 and a dividend yield of 0.64%.

Today the stock has traded between $54.85 and $56.94. The current price is 2.0% above the day's low and 1.8% below its high.

Volume so far is 1.57M shares, below the average of 2.16M shares a day.

Over the past year Bruker has ranged from $32.37 to $66.98, and now sits 68% of the way up that range.

Bruker met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $0.49 per share against an estimate of $0.3924.

The average analyst price target is $61.18, 9.4% above the current price, from 15 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

47%of 15 analyst ratings say Buy
  • Buy46.7%
  • Hold46.7%
  • Sell6.7%
Price target · 15 analystsAvg $61.18
Low
$50.50
Now
$55.93
High
$73.50

BRKR earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 18.9% on average.

  1. Q3 FY24: reported $0.60 per share against an estimate of $0.6055
  2. Q4 FY24: reported $0.76 per share against an estimate of $0.7513
  3. Q1 FY25: reported $0.47 per share against an estimate of $0.441
  4. Q2 FY25: reported $0.32 per share against an estimate of $0.4325
  5. Q3 FY25: reported $0.45 per share against an estimate of $0.3417
  6. Q4 FY25: reported $0.59 per share against an estimate of $0.6622
  7. Q1 FY26: reported $0.31 per share against an estimate of $0.2382
  8. Q2 FY26: reported $0.49 per share against an estimate of $0.3924

BRKR news

  • Press releaseBusiness Wire

    Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast

  • Press releaseBusiness Wire

    Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution

  • Press releaseBusiness Wire

    Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research

  • Press releaseBusiness Wire

    Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley

  • Press releaseBusiness Wire

    Bruker Corporation to Present at Upcoming Investor Conferences

  • Press releaseBusiness Wire

    BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion

  • Vandana Singh

    Jury Awards 10x Genomics Millions in Patent Lawsuit Against Qiagen Unit

  • Press releaseBusiness Wire

    Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

Similar companies

Companies in the same industry as Bruker

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.